MGuard Prime commercial re-launch complete in direct markets   Drug Eluting Stent (DES) program advances in development with partners — MASTER II trial to suspend enrollment to support DES and … Continue reading InspireMD Resumes MGuard Prime Sales and Prioritizes DES and Carotid – New Product Programs